Other biomarkers are currently under investigation, such as tumor mutational burden, the presence of tumor-infiltrating lymphocytes, microsatellite instability, LDH levels, the presence of visceral disease, major histocompatibility complex, the detection of circulating tumor DNA, the value of CD274 amplifications, and immune gene expression profiles [131,132,133,134]. Here, CD274 is linked to neoplasm.